|Articles|June 15, 2004
Topical cyclosporine can handle more than just dry eye disease
Any T cell-mediated disease found to benefit from this therapy without affecting other inflammatory pathways
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
























